Drawing for NANOSHUTTLE

USPTO serial 85102934

NANOSHUTTLE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FRYE, KIMBERLY
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NANOSHUTTLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of anti-cancer drugs; Artificial plant-cultivation soil; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biological tissue, namely, SHED stem cells (stem cells from human exfoliated deciduous teeth), dental pulp and human maxiofacial bone elements for scientific use and research in cellular healing therapies; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biotechnology formed genes, microbes and enzymes for use in the production of agricultural seeds to enhance plants' growth therefrom; Carbon nano particles, namely, carbon nano particles that photoluminesce; Cells for scientific, laboratory or medical research; Chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purposes; Chemical gel for use as an ice substitute; Chemical reagents for non-medical purposes; Chemically activated adhesive label for sensing the presence of oxygen in intravenous medical and pharmaceutical containers; Chemically treated non-medical test strips for calibration of laboratory test equipment; Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Cultures of microorganisms other than for medical and veterinary use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Electrophoresis gels other than for medical or veterinary purposes; Enzymes derived from biotechnological processes for use in industry; Enzymes for scientific and research purposes; Food supplements for agricultural products and other plants; Growing media for plants; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Magnetic fluid for industrial purposes; Medical grade polyurethanes for use in the manufacture of medical tubing, films, sprays, and membranes; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Nutritive additive to enhance the biological activity of water, soil, seeds and plants for purposes of fertilization and bioremediation of pollutants; Plant and herb extracts for use in the manufacture of cosmetics; Plant extracts for use in the manufacture of creams, lotions and cosmetic products; Plant extracts, namely phytochemicals, used in the manufacture of medical products; Plant food; Plant growth regulating preparations; Plant growth regulators for agricultural use; Plant hormones (phytohormones); Plant nutrition preparations; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Preparations for fortifying plants; Protein arrays and nucleotide arrays for scientific and medical research; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Reagents for scientific or medical research use; Reagents for testing the sterility of medical equipment; Reagents for use in scientific apparatus for chemical or biological analysis; Silica gel; Stem cells for research or scientific purposes; Stem cells for research purposes; Substances for regulating plant growth; Synthetic amorphous silica gel for further processing in connection with the manufacture of finished goods; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 6, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 6, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 27, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 27, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 27, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2010DOCKASSIGNED TO EXAMINER—
Aug 13, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 12, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 12, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance